Prometheus Life Technologies is a pioneering healthcare startup that focuses on developing innovative biotech solutions by harnessing the unique environment of space. The company has created disruptive, space-proven technology for producing high-quality human tissue organoids in low Earth orbit, aimed at improving drug testing processes while significantly reducing reliance on animal testing. Their organoids are 3D in vitro culture systems derived from self-organizing stem cells that closely mimic original tissue architecture and functionality. This approach not only enhances pharmaceutical research and precision medicine but also opens new doors for regenerative medicine and transplantation therapies. The company is based at the University of Zurich and has a mission centered on creating better therapies to benefit millions, utilizing the advantages of microgravity to achieve scalable organoid production free from earthly limitations.